Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06441747
What this trial is testing

Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

Who this might be right for
Cholangiocarcinoma
Australasian Gastro-Intestinal Trials Group 40
Testing effectiveness (Phase 2)UnknownNCT04131621
What this trial is testing

Nivolumab/Ipilimumab in Second Line CUP-syndrome

Who this might be right for
Cancer of Unknown Primary Site
University Hospital Heidelberg 194
Testing effectiveness (Phase 2)UnknownNCT04056949
What this trial is testing

Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Junling Li 30
Not applicableEnded earlyNCT02145390
What this trial is testing

Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Bladder CancerBladder CarcinomaTransition Cell Cancer+1 more
University of Miami 1
Not applicableUnknownNCT06091683
What this trial is testing

Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC)

Who this might be right for
Peritoneal Metastases From Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 10
Testing effectiveness (Phase 2)Study completedNCT02560337
What this trial is testing

Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.

Who this might be right for
Ovarian Cancer
Vejle Hospital 26
Testing effectiveness (Phase 2)Study completedNCT01108107
What this trial is testing

Neoadjuvant Treatment of Colon Cancer

Who this might be right for
Colon Cancer
Vejle Hospital 76
Very early researchWithdrawnNCT03295695
What this trial is testing

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Who this might be right for
Breast CancerBreast Cancer, FemaleBreast Cancer, Male+1 more
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Study completedNCT01574937
What this trial is testing

XL-184+Abiraterone in Post-Chemo CRPC

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 27
Testing effectiveness (Phase 2)Study completedNCT00003007
What this trial is testing

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Tennessee
Testing effectiveness (Phase 2)Temporarily pausedNCT05948553
What this trial is testing

Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine

Who this might be right for
Post Traumatic Stress Disorder
Global Coalition for Adaptive Research 200
Testing effectiveness (Phase 2)UnknownNCT01707329
What this trial is testing

Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment

Who this might be right for
Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT01801137
What this trial is testing

The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium

Who this might be right for
Urothelial Cancer
Hopital Foch 54
Testing effectiveness (Phase 2)Ended earlyNCT00551759
What this trial is testing

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Eastern Cooperative Oncology Group 22
Testing effectiveness (Phase 2)Study completedNCT01575860
What this trial is testing

Maintenance Lenalidomide in Lymphoma

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05994001
What this trial is testing

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Who this might be right for
Biliary Tract CancerCandonilimabClaudin 18.2
Shanghai Zhongshan Hospital 78
Testing effectiveness (Phase 2)Looking for participantsNCT07330037
What this trial is testing

TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 41
Post-approval studies (Phase 4)Study completedNCT01401075
What this trial is testing

RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients

Who this might be right for
Gastric Cancer
Abnoba Gmbh 32
Large-scale testing (Phase 3)Study completedNCT02511639
What this trial is testing

Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer Metastatic
Istituto Oncologico Veneto IRCCS 110
Testing effectiveness (Phase 2)Study completedNCT00003877
What this trial is testing

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 30
Next Page